The emerging threat of methicillin-resistant Staphylococcus aureus (MRSA) clone ST22-PT, carrying both Panton–Valentine leucocidin and toxic shock syndrome toxin 1 genes
Journal of Antimicrobial Chemotherapy · 03.04.2023 · 78 (4) · 1023-1027
DOI: 10.1093/jac/dkad039 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Antimicrobial Chemotherapy, online erschienen am 23.02.2023. Verfasst von Hiroshi Kaneko und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Microbiology, School of Pharmacy, Tokyo University of Pharmacy and Life Sciences, 1432-1 Horinouchi, Hachioji, Tokyo 192-0392,…. Hauptthemen laut MEDLINE: Methicillin-Resistant Staphylococcus aureus, Shock, Septic, Staphylococcal Infections. Die Arbeit wurde bisher 30-mal zitiert (Crossref) und nennt 20 Literaturangaben. Gefördert von: Japan Society for the Promotion of Science.
Abstract (Originalsprache)
Objectives
Some MRSA strains produce Panton–Valentine leucocidin (PVL) and/or toxic shock syndrome toxin 1 (TSST-1), which are associated with severe infectious diseases. Although PVL- or TSST-1-positive strains have been isolated worldwide, strains carrying both PVL and TSST-1 genes are rare and sporadic. The objective of this study was to characterize these strains from Japan.
Methods
A total of 6433 MRSA strains isolated in Japan between 2015 and 2021 were analysed. Molecular epidemiological and comparative genomic analyses were conducted on PVL- and TSST-1-positive MRSA strains.
Results
A total of 26 strains from 12 healthcare facilities were PVL positive and TSST-1 positive, and all were classified as clonal complex (CC) 22. These strains exhibited similar genetic features to each other and were named as ST22-PT according to a previous report. Twelve and one of the ST22-PT strains were identified in patients with deep-seated skin infections and toxic shock syndrome-like symptoms, which are typical clinical features of PVL-positive and TSST-1-positive Staphylococcus aureus, respectively. Whole-genome comparative analysis revealed that the ST22-PT strains were highly similar to PVL- and TSST-1-positive CC22 strains isolated in several countries. Evaluation of the genome structure showed that ST22-PT possessed ΦSa2 harbouring PVL genes and a unique S. aureus pathogenicity island harbouring the TSST-1 gene.
Conclusions
ST22-PT strains have recently emerged from several healthcare facilities in Japan, and ST22-PT-like strains have been identified in several countries. Our report highlights that the risk of international spread of PVL- and TSST-1-positive MRSA clone ST22-PT needs to be further investigated.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Clinical Microbiology, School of Pharmacy, Tokyo University of Pharmacy and Life Sciences, 1432-1 Horinouchi, Hachioji, Tokyo 192-0392, Japan.
ORCID-Profile: Hiroshi Kaneko, Hidemasa Nakaminami
Förderung
- Japan Society for the Promotion of Science
Zitieren
APA
Kaneko, H., Yanagi, Y., Otake, S., Sato, M., Saito, T., & Nakaminami, H. (2023). The emerging threat of methicillin-resistant Staphylococcus aureus (MRSA) clone ST22-PT, carrying both Panton–Valentine leucocidin and toxic shock syndrome toxin 1 genes. Journal of Antimicrobial Chemotherapy, 78(4), 1023-1027. https://doi.org/10.1093/jac/dkad039
Vancouver
Kaneko H, Yanagi Y, Otake S, Sato M, Saito T, Nakaminami H. The emerging threat of methicillin-resistant Staphylococcus aureus (MRSA) clone ST22-PT, carrying both Panton–Valentine leucocidin and toxic shock syndrome toxin 1 genes. Journal of Antimicrobial Chemotherapy. 2023;78(4):1023-1027. doi:10.1093/jac/dkad039
BibTeX
@article{Kaneko2023,
author = {Kaneko, Hiroshi and Yanagi, Yuka and Otake, Shogo and Sato, Mayu and Saito, Takumi and Nakaminami, Hidemasa},
title = {The emerging threat of methicillin-resistant Staphylococcus aureus (MRSA) clone ST22-PT, carrying both Panton–Valentine leucocidin and toxic shock syndrome toxin 1 genes},
journal = {Journal of Antimicrobial Chemotherapy},
year = {2023},
volume = {78},
number = {4},
pages = {1023--1027},
doi = {10.1093/jac/dkad039}
}
EUVIMED